2025 HCPCS Code Q0239
Injection, bamlanivimab-xxxx, 700 mg
| Notice | HCPCS Q0239 terminated on April 16, 2021. |
| Short Description | Bamlanivimab-xxxx |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | November 09, 2020 |
| HCPCS Action Effective Date | April 17, 2021 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q0244 - Casirivi and imdevi 1200 mg
- Q0245 - Bamlanivimab and etesevima
- Q0247 - Sotrovimab
- Q0249 - Tocilizumab for covid-19
- Q0477 - Pwr module pt cable lvad rpl
- Q0478 - Power adapter, combo vad
- Q0479 - Power module combo vad, rep
- Q0480 - Driver pneumatic vad, rep
- Q0481 - Microprcsr cu elec vad, rep
- Q0482 - Microprcsr cu combo vad, rep
- Q0483 - Monitor elec vad, rep
- Q0484 - Monitor elec or comb vad rep
- Q0485 - Monitor cable elec vad, rep
- Q0486 - Mon cable elec/pneum vad rep
- Q0487 - Leads any type vad, rep only
- Q0488 - Pwr pack base elec vad, rep
- Q0489 - Pwr pck base combo vad, rep
- Q0490 - Emr pwr source elec vad, rep
- Q0491 - Emr pwr source combo vad rep
- Q0492 - Emr pwr cbl elec vad, rep